|
Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 Clinical research trials and Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1. Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 clinical trial. Test subjects typically receive the most effective healthcare possible for their Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
For Condition: Cocaine-Related Disorders
Status: No longer recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) , Somerset Pharmaceuticals
Synopsis: Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence
Details: The study objectives are to assess the efficacy and safety of the Selegiline Transdermal System (STS) in reducing cocaine use in subjects with cocaine dependence. It is hypothesized that selegiline treatment compared to placebo, will be associated with fewer days of cocaine use as assessed by self-report confirmed with urine assays for benzoylecgonine (BE).
Eligibility:
Study Type: Interventional, Placebo Control
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Please contact site for information Inclusion Criteria: Male/Female, at least 18 years of age, DSM-4 diagnosis of cocaine dependence, ability to understand and provide written consent, female subjects - must use acceptable birth control Exclusion Criteria: Additional Criteria available during the screening process at the site.
Total Enrollment: 269
Location and Contact Information:
Overall Study Official:
LizaGorgon, Principal Investigator, University of Pennsylvania
San Francisco General Hosptial
San Francisco, California, 94110
United States
VA Maryland Healthcare System
Baltimore, Maryland, 21201
United States
Denver VA Medical Center
Denver, Colorado, 80220
United States
Haight-Ashbury Free Clinic
Berkeley, California, 94704
United States
New Orleans VA Medical Center
New Orleans, Louisiana, 70112
United States
Medical University of South Carolina
Charleston, South Carolina, 29425 742
United States
VA Puget Sound Health Care System
Seattle, Washington, 98108
United States
San Francisco VA Medical Center
San Francisco, California, 94121
United States
University of Texas Hlth Sci Ctr Houston
Houston, Texas, 77030
United States
Cincinnati VA Medical Center
Cincinnati, Ohio, 45220
United States
Friends Research Institute
Los Angeles, California, 90025
United States
Tucson VA Medical Center
Tucson, Arizona, 85723
United States
Wayne State University
Detroit, Michigan, 48207
United States
VA North Texas Health Care System
Dallas, Texas, 75216
United States
Salt Lake City VA Medical Center
Salt Lake City, Utah, 84148
United States
Friends Research Institute-2
Los Angeles, California, 90025
United States
Additional Information:
Study ID Numbers: NIDA-CSP-1019-1;
Study Start Date: March 2001
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00032929
Other Cocaine-Related Disorders Studies:
1. Amphetamine Cocaine Interaction Study - 2
2. Cocaine Abuse and ADHD - 10
3. Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
4. Efficacy of Nefazodone in Cocaine Dependent Subjects - 4
5. Effects of Carvedilol on Cocaine use in Humans - 11
Related Studies:
Other Cocaine-Related Disorders Clinical Trials
Other South Carolina Clinical Trials
Other Charleston Clinical Trials
Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
|
|
|
|
|
|
|
|